logo

Enter Symbol

PHARMA PRO(NSDQ:PPDI)
As a leading global provider of discovery and development services and products for pharmaceutical, biotechnology and medical device companies, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients maximize the return on their R&D investments. With proven discovery through post-market resources, the company also offers compound partnering opportunities. PPD has more than 6,600 professionals in 27 countries around the world. For more information on PPD, visit the Web site at http://www.ppdi.com.
# Employees: 10500
Address: 929 North Front Street,Wilmington,NC,USA
Phone: 910-251-0081
Fax: 910-772-7056
Website: www.ppdi.com
Email: info@wilm.ppdi.com
Sector: Medical
Industry: MED-DRUGS
Executive Officers
Fredric N. Eshelman Ph.D. (Vice-Chmn.; C.E.O.)
William W. Richardson (Sr. V.P.; Global Business Devlp.)
Paul S. Covington M.D. (Exec. V.P. Development)
Daniel Daraszdi (C.F.O.)
William J. Sharbaugh (C.O.O.,)
Dividend
Ex-Dividend Date: 9/11/2009
Annual Dividend: $0.60
Current Dividend Yield: $2.85
Dividend Paid (3 months): $0.15
Indicated Dividend: $0.41
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 2/8/2010
Mean EPS (Next Qtr): $0.25
Mean EPS (Year): $1.29
Mean Estimate(Long Term): $11.20
P/E Ratio(Based on EPS estimate): 16.340
Number of Estimates: 10
Shares Performance
Period PPDI Compare to S&P
YTD -27.54 % -40.03 %
4 Weeks -8.81 % -9.79 %
12 Weeks 4.01 % -1.94 %
Shares Information
Analyst Coverage: Y
Avg Volume: 1527170
Shares Outstanding: 118M
Market Cap: $2.48B
52 Week High: $29.01
52 Week Low: $18.50
P/E Ratio: 14.200
PEG Ratio: 1.460
Split: On 3/1/2006 PPDI split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: 3.03 %
EPS Growth in Last Year: -22.73 %
Sales Growth in Last Quarter: -3.99 %
Sales Growth in Last Quarter: -14.41 %
Financials
Qtr Book Value: $1.86
Cash Flow/Share: $9.40
Change in Payout Ratio: 0.250
Price/Sales: 1.740
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia